RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Gamma Biosciences
G

Gamma Biosciences portfolio

Gamma Biosciences has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $24M.
Latest deal: Acta Pharmaceuticals · Oct 15, 2026.
About this page

Its most recent investment on record is Acta Pharmaceuticals's $24M Seed round in October 2026, alongside Alzheimer's Research Foundation and Dolby Family Ventures. That company is in Health and bio.

What Gamma Biosciences invests in

How Gamma Biosciences invests

StageDealsCapital in rounds
Seed 1 100%$24M

Gamma Biosciences portfolio companies

CompanyRound with Gamma BiosciencesTotal raisedLatest raise
AActa Pharmaceuticals
Health and bio
Seed · $24M$24MOct 15, 2026
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Gamma Biosciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Gamma Biosciences, which is a subset of its real portfolio. API: /api/v1/investors/gamma-biosciences (get a free API key). More: the most active VC firms and new venture capital funds.